This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
BioLegend
other brands :
Babco, Signet, Sternberger Monoclonals, Senetek, Covance
product type :
antibody
product name :
LEAF™ Purified anti-human GM-CSF
catalog :
502204
quantity :
500 μg
price :
280 USD
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
BVD2-23B6
reactivity :
human
application :
western blot, ELISA, neutralization, immunoprecipitation
citations: 1
product information
Antigen :
GM-CSF
Apps. Abbrev. :
ELISA Capture, ELISPOT Capture, IP, Neut, Western Blotting
Cat # :
502204
Clone :
BVD2-23B6
Item :
LEAF™ Purified anti-human GM-CSF
Isotype :
Rat IgG2a, κ
Other Names :
Granulocyte/macrophage colony-stimulating factor, CSF-α, Pluripoietin-α, Eosinophil colony stimulating factor (Eo-CSF), Burst promoting activity (BPA)
Size :
500 μg
Price (USD) :
280 USD
Reactivity :
Human
Clonality :
Monoclonal
Host :
Rat
Conjugate/Tag/Label :
LEAF
Immunogen :
E. coli -expressed, recombinant human GM-CSF
Application Notes :
ELISA or ELISPOT Capture 1-6 : The Purified BVD2-23B6 antibody is useful as the capture antibody in a sandwich ELISA or ELISPOT assay, when used in conjunction with the biotinylated BVD2-21C11 antibody (Cat. No. 502304) as the detecting antibody. The Ultra-LEAF™ Purified antibody is suggested for ELISPOT capture. Neutralization 1-4 : The Ultra-LEAF™ Purified antibody (Endotoxin 0.01 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for neutralization of human GM-CSF bioactivity (Cat. Nos. 502205 - 502210). Additional reported applications (for the relevant formats) include: immunoprecipitation 3 and Western blotting. Note: For testing human GM-CSF in serum or plasma, BioLegend's ELISA Max™ Sets (Cat. Nos. 432001 and 432004) are specially developed and recommended.
company information

BioLegend
8999 BioLegend Way
San Diego, CA 92121
San Diego, CA 92121
customerserv@biolegend.com
https://www.biolegend.comheadquarters: USA
questions and comments